Medical device suppliers’ merger raises CMA concernsChristian Fernsby ▼ | July 1, 2020
The Competition and Markets Authority (CMA) is concerned that, should the proposed £4.2 billion purchase by Stryker Corporation of Wright Medical Group N.V. go ahead, it would have a negative impact on vulnerable patients in the UK who need ankle replacements.
Wright Medical Group Stryker Corporation
Following its initial Phase 1 investigation, the CMA found that the proposed merger would result in the merged entity having a share of over 90% in the total ankle replacement prostheses market in the UK.
Should the deal go ahead as planned, the CMA is concerned that Stryker would not face enough competition from other suppliers, leading to higher prices or less choice for hospitals and their patients. ■